multiprogram trial stimulator mts (St Jude Medical)
Structured Review
Multiprogram Trial Stimulator Mts, supplied by St Jude Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiprogram+trial+stimulator+mts/mts+external+stimulator+programmer/pm23294166-101-9-13
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Systems and methods for model-based optimization of spinal cord stimulation electrodes and devices Article Snippet: The extradural array was connected to an external Article Title: Neuroplasticity-dependent and -independent mechanisms of chronic deep brain stimulation in stressed rats Article Snippet: DBS was conducted for 3 consecutive weeks ( Article Title: Evaluation of Intradural Stimulation Efficiency and Selectivity in a Computational Model of Spinal Cord Stimulation Article Snippet: The extradural array was connected to an external Article Title: Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Article Snippet: http://dx.doi.org/10.1016/j.pain.2014.08.031 0304-3959/ 2014 International Association for the Study of Pain.. Published by Elsevier B.V. All rights reserved.. ⇑ Corresponding author at: Department of Neurosurgery, Medisch Spectrum Twente, PO Box 50.000, 7500 KA Enschede, The Netherlands. Article Title: Successful treatment of the pain associated with melorheostosis with spinal cord stimulation: a case study. Article Snippet: To the Editor: INTRODUCTION Melorheostosis (also known as Leri’s disease) is a rare, nonhereditary, sclerotic bone dysplasia that is characterized by a thickening of the bone (1,2).. On X-ray, the appearance of melorheostosis can be likened to the flowing wax of a melting candle.. Although the disease can present at any age, the peak age range is from 5 to 20 years (2–5). Article Title: Long-term outcomes of spinal cord stimulation with percutaneously introduced paddle leads in the treatment of failed back surgery syndrome and lumboischialgia. Article Snippet: Methods: Twenty-one patients diagnosed with failed back surgery syndrome (FBSS) or lumboischialgia were implanted with a small profile plate-type electrode.. Patients were followed-up long term and were asked at baseline, after trial, and during each follow-up visit to score their pain on a visual analog scale (VAS) for pain now, worst pain last week, least pain last week, and mean pain last week.. Pain location, electrophysiologic parameters, and number of reprogrammings were collected as well. Article Title: Cervical spinal cord stimulation for prevention and treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: clinical and radiographic outcomes of a prospective single-center clinical pilot study. Article Snippet: Background Cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage (aSAH) is a major cause of high morbidity and mortality, for which there is no consistently effective treatment.. Cervical spinal cord stimulation (cSCS) has been shown to induce vasodilatation and improve peripheral and cerebral blood flow in both animal and human studies.. This pilot study was performed to assess the clinical effect and long-term results of cSCS treatment in aSAH patients. |
